General Information of the Compound
| Compound ID |
CP0891110
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2-(4-chlorophenyl)-3-((4-(pyridazine-4-carbonyl)piperazin-1-yl)methyl)imidazo[1,2-a]pyridin-6-yl)-N-methylmethanesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H26ClN7O3S
|
||||||||||||||||||
| Molecular Weight |
540.049
|
||||||||||||||||||
| Canonical SMILES |
CN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCN(C(=O)c4ccnnc4)CC3)n2c1)S(C)(=O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H26ClN7O3S/c1-30(37(2,35)36)21-7-8-23-29-24(18-3-5-20(26)6-4-18)22(33(23)16-21)17-31-11-13-32(14-12-31)25(34)19-9-10-27-28-15-19/h3-10,15-16H,11-14,17H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
QWBFJXSZSFCANR-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04657, Solute carrier family 2, facilitated glucose transporter member 1
Protein ID: PT06319, Solute carrier family 2, facilitated glucose transporter member 2
Protein ID: PT06387, Solute carrier family 2, facilitated glucose transporter member 3
Protein ID: PT03440, Solute carrier family 2, facilitated glucose transporter member 4